CELLINK acquires MatTek for $68M in bid to develop cruelty-free drug testing model

Swedish 3D bioprinter manufacturer CELLINK has agreed to acquire the in-vitro technology specialist MatTek Corporation for $68 million.  The deal, which is expected to be finalized next week, will see CELLINK pay $13.6 million of the purchase price in shares, and the remaining $54.4 million in cash, to gain full control of MatTek. Given the […]